Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 8,900 shares at $302.25 ($2.7M) on 2024-11-01, disclosed to the SEC on 2024-11-05.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.10 | 2,800 | $840K | 31.4% |
| 2 | $300.10 | 2,800 | $840K | 31.4% |
| 3 | $301.22 | 1,100 | $331K | 12.4% |
| 4 | $301.22 | 1,100 | $331K | 12.4% |
| 5 | $302.25 | 800 | $242K | 9.0% |
| 6 | $304.29 | 300 |
| $91K |
| 3.4% |
| Total | $300.71 avg | 8,900 | $2.7M | 100% |
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $4.1M | — | Filing → |